stella
beta
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma — Stella
Recruiting
Back to Glioblastoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(4 sites)
United States
Chan Soon-Shiong Institute for Medicine (CSSIFM), El Segundo, California
Providence Medical Foundation, Fullerton, California
Hoag Memorial Hospital Presbyterian, Newport Beach, California
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee
View full record on ClinicalTrials.gov